list of glp 1 receptor agonists PDF] Glucagon-Like Peptide-1 (GLP-1) Receptor

Additionally, for individuals with type 2 diabetes, obesity, and heart failure with preserved ejection fraction, GLP-1 receptor agonists are advised to manage glucose and alleviate heart failure symptoms

Researchers believe that nausea/vomiting is related to greater weight loss (90)

In patients with CKD who are at increased risk for cardiovascular events, use of a GLP-1 RA may reduce the risk of progression of albuminuria, cardiovascular events, or both

It has several far-reaching consequences like increased incidence of heart diseases, diabetes, depression, reduced quality of life and even death

Gastrointestinal intolerance, particularly nausea and vomiting, may affect adherence despite their tendency to diminish over time (Liu et al., 2022)

Efficacy and safety of long-acting glucagon-like peptide-1 receptor agonists compared with exenatide twice daily and sitagliptin in type 2 diabetes mellitus: A systematic review and meta-analysis